Munich- and Boston-based private equity firm TVM Capital has regrouped its life science investment practice by separating operations into two specialist teams: a life science-focused venture capital arm and healthcare private equity division.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.